The t(9;14)(p13;q32) Translocation in B-Cell Non-Hodgkin's Lymphoma
- 1 January 2000
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 36 (5-6), 435-445
- https://doi.org/10.3109/10428190009148390
Abstract
T(9;14)(p13;q32) is a rare but recurring translocation found in a subset of B-cell non-Hodgkin's lymphoma (B-NHL). These lymphomas share clinical features with chronic lymphocytic leukemia and are further characterized by plasmacytoid differentiation of lymphoma cells. Molecular cloning of t(9;14)(p13;q32) revealed juxtaposition of the PAX5 to the immunoglobulin heavy chain gene (IGH), although breakpoints on both genes were variable. The PAX5 gene encodes the BSAP (B-cell-specific activator protein) transcription factor, which is expressed throughout the process of B-cell development except in terminally differentiated plasma cells. t(9;14)(p13;q32) consistently leaves the PAX5 coding region intact, most likely resulting in deregulated expression of the gene product due to the proximity of IGH. The majority cases of B-cell tumors expressed considerable levels of PAX5/BSAP irrespective of whether they exhibited t(9;14)(p13;q32), suggesting that quantitative differences in expression level alone may not account for the development of this particular subtype of B-NHL.Keywords
This publication has 48 references indexed in Scilit:
- Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B‐cell non‐Hodgkin's lymphomaBritish Journal of Haematology, 1998
- Pax‐5 is identical to EBB‐1/KLP and binds to the VpreB and λ5 promoters as well as the KI and KII sites upstream of the Jχ genesEuropean Journal of Immunology, 1997
- BSAP: a key regulator of B-cell development and differentiationImmunology Today, 1995
- Chromosomal translocations in human cancerNature, 1994
- Molecular mechanisms regulating CD19, CD20 and CD22 gene expressionImmunology Today, 1994
- The CD19/CD21 signal transduction complex of B lymphocytesImmunology Today, 1994
- Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993
- A pre‐B‐ and B cell‐specific DNA‐binding protein, EBB‐1, which binds to the promoter of the VpreB1 geneEuropean Journal of Immunology, 1992
- A Novel B Cell Line Established from Ki‐1‐positive Diffuse Large Cell LymphomaJapanese Journal of Cancer Research, 1988
- Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphomaCancer Genetics and Cytogenetics, 1984